Page last updated: 2024-08-24

tepoxalin and Alzheimer Disease

tepoxalin has been researched along with Alzheimer Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bauer, J; Butcher, RD; Fiebich, BL; Hofer, TJ; Huell, M; Lieb, K; Schulze-Osthoff, K; Schumann, G	1

Other Studies

1 other study(ies) available for tepoxalin and Alzheimer Disease

Article	Year
The non-steroidal anti-inflammatory drug tepoxalin inhibits interleukin-6 and alpha1-anti-chymotrypsin synthesis in astrocytes by preventing degradation of IkappaB-alpha. Neuropharmacology, 1999, Volume: 38, Issue:9 Topics: alpha 1-Antichymotrypsin; Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Astrocytes; Cell Line; Cells, Cultured; DNA-Binding Proteins; Humans; I-kappa B Proteins; Interleukin-1; Interleukin-6; Microglia; NF-kappa B; NF-KappaB Inhibitor alpha; Pyrazoles; Rats; Rats, Wistar	1999

Article

Year

The non-steroidal anti-inflammatory drug tepoxalin inhibits interleukin-6 and alpha1-anti-chymotrypsin synthesis in astrocytes by preventing degradation of IkappaB-alpha.

Neuropharmacology, 1999, Volume: 38, Issue:9

Topics: alpha 1-Antichymotrypsin; Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Astrocytes; Cell Line; Cells, Cultured; DNA-Binding Proteins; Humans; I-kappa B Proteins; Interleukin-1; Interleukin-6; Microglia; NF-kappa B; NF-KappaB Inhibitor alpha; Pyrazoles; Rats; Rats, Wistar

1999